Manuel C. Vallejo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Manuel C. Vallejo has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Sivam Ramanathan
12 shared publicationsAmy L. Phelps
Duquesne University School of Business; Pittsburgh; Pennsylvania; USA
8 shared publicationsBupesh Kaul
6 shared publicationsGordon L. Mandell
5 shared publicationsNeera Sah
4 shared publicationsBenjamin T. Cobb
University of Pittsburgh School of Medicine; Pittsburgh; Pennsylvania; USA
2 shared publications
Latest Publications
- 30 September 2013
- Published by Elsevier in Anesthesiology Clinics
- Vol. 31 (3) , 517-528
The Changing Role of Magnesium in Obstetric Practice
- 30 September 2013
- Published by Elsevier in Anesthesiology Clinics
- Vol. 31 (3) , 517-528
The Changing Role of Magnesium in Obstetric Practice
- 1 August 2013
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 25 (5) , 417-423
Anesthetic care of parturients with single ventricle physiology
- 1 August 2013
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 25 (5) , 417-423
Anesthetic care of parturients with single ventricle physiology
- 4 April 2013
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 53 (4) , 369-374
Maternal outcomes in women supplemented with a high-protein drink in labour
Background Because of the potential aspiration risk, oral intake is restricted during labour. Aims To determine whether high-protein drink supplementation in labour decreases nausea and emesis and promotes patient satisfaction. Materials and Methods The study was registered with www.clinicaltrials.gov (NCT01414478). Labouring women were randomised into two groups: Group P received a high-protein drink (325 mL) with ice chips/water PRN; and Group C served as control and received only ice chips/water PRN (Study 1). Incidences of nausea and emesis were measured hourly until delivery and at 1 h postdelivery. Patient satisfaction was measured the following day. A secondary aim was to evaluate the rate of gastric emptying (t½) in women who ingested either 325 mL of a high-protein drink or ice chips/water (Study 2) using ultrasound. Results In Study 1, 150 women were recruited (Group P = 75; Group C = 75). There were no differences in the overall incidences of nausea (P = 0.14), emesis (P = 0.15) or in the incidences at the measured time periods (MANOVA, P > 0.05). Median patient satisfaction scores were higher in Group P than in Group C (P = 0.007). In Study 2, 18 additional patients (Group PG = 9; Group CG = 9) were analysed to determine US gastric emptying t½ rates (PG: 25.56 ± 15.90 min [95% CI: 15.17 – 35.94] compared with CG: 20.00 ± 8.70 min [95% CI: 14.34 – 25.66], P = 0.19). Conclusion In labour, patient satisfaction is improved with high-protein drink supplementation compared with ice chips/water with comparable gastric emptying rates.
- 4 April 2013
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 53 (4) , 369-374
Maternal outcomes in women supplemented with a high-protein drink in labour
Background Because of the potential aspiration risk, oral intake is restricted during labour. Aims To determine whether high-protein drink supplementation in labour decreases nausea and emesis and promotes patient satisfaction. Materials and Methods The study was registered with www.clinicaltrials.gov (NCT01414478). Labouring women were randomised into two groups: Group P received a high-protein drink (325 mL) with ice chips/water PRN; and Group C served as control and received only ice chips/water PRN (Study 1). Incidences of nausea and emesis were measured hourly until delivery and at 1 h postdelivery. Patient satisfaction was measured the following day. A secondary aim was to evaluate the rate of gastric emptying (t½) in women who ingested either 325 mL of a high-protein drink or ice chips/water (Study 2) using ultrasound. Results In Study 1, 150 women were recruited (Group P = 75; Group C = 75). There were no differences in the overall incidences of nausea (P = 0.14), emesis (P = 0.15) or in the incidences at the measured time periods (MANOVA, P > 0.05). Median patient satisfaction scores were higher in Group P than in Group C (P = 0.007). In Study 2, 18 additional patients (Group PG = 9; Group CG = 9) were analysed to determine US gastric emptying t½ rates (PG: 25.56 ± 15.90 min [95% CI: 15.17 – 35.94] compared with CG: 20.00 ± 8.70 min [95% CI: 14.34 – 25.66], P = 0.19). Conclusion In labour, patient satisfaction is improved with high-protein drink supplementation compared with ice chips/water with comparable gastric emptying rates.
- 1 February 2012
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 129 (2) , 519-526
Aprepitant plus Ondansetron Compared with Ondansetron Alone in Reducing Postoperative Nausea and Vomiting in Ambulatory Patients Undergoing Plastic Surgery
Postoperative nausea and vomiting is a major challenge in the perioperative setting. The incidence can be as high as 80 percent, and the majority of the symptoms among outpatients occur after discharge. This study evaluated the efficacy of a neurokinin-1 receptor antagonist (aprepitant) in reducing postoperative symptoms for up to 48 hours in patients undergoing outpatient plastic surgery. A prospective, double-blinded, randomized, two-arm evaluation of 150 ambulatory plastic surgery patients receiving a standardized general anesthetic, including postoperative nausea and vomiting prophylaxis with ondansetron and either aprepitant or placebo, was performed. The main outcome measures were the occurrence of vomiting and the severity of nausea for up to 48 hours postoperatively. Overall, 9.3 percent of patients who received aprepitant versus 29.7 percent in group B had vomiting, with the majority of vomiting episodes occurring after hospital discharge. The Kaplan-Meier plot of the hazards of vomiting revealed an increased incidence of emesis in patients receiving ondansetron alone compared with the combination of ondansetron and aprepitant (p = 0.006). The incidence of nausea was not significantly different in the two groups. Severity of nausea, however, was significantly higher in those receiving ondansetron alone compared with those receiving ondansetron and aprepitant, as measured by a peak nausea score (p = 0.014) and by multivariate analysis of variance results comparing repeated verbal rating scale scores over 48 hours after surgery (p = 0.024). In patients undergoing plastic surgery, the addition of aprepitant to ondansetron significantly decreases postoperative vomiting rates and nausea severity for up to 48 hours postoperatively. Therapeutic, II.
- 1 February 2012
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 129 (2) , 519-526
Aprepitant plus Ondansetron Compared with Ondansetron Alone in Reducing Postoperative Nausea and Vomiting in Ambulatory Patients Undergoing Plastic Surgery
Postoperative nausea and vomiting is a major challenge in the perioperative setting. The incidence can be as high as 80 percent, and the majority of the symptoms among outpatients occur after discharge. This study evaluated the efficacy of a neurokinin-1 receptor antagonist (aprepitant) in reducing postoperative symptoms for up to 48 hours in patients undergoing outpatient plastic surgery. A prospective, double-blinded, randomized, two-arm evaluation of 150 ambulatory plastic surgery patients receiving a standardized general anesthetic, including postoperative nausea and vomiting prophylaxis with ondansetron and either aprepitant or placebo, was performed. The main outcome measures were the occurrence of vomiting and the severity of nausea for up to 48 hours postoperatively. Overall, 9.3 percent of patients who received aprepitant versus 29.7 percent in group B had vomiting, with the majority of vomiting episodes occurring after hospital discharge. The Kaplan-Meier plot of the hazards of vomiting revealed an increased incidence of emesis in patients receiving ondansetron alone compared with the combination of ondansetron and aprepitant (p = 0.006). The incidence of nausea was not significantly different in the two groups. Severity of nausea, however, was significantly higher in those receiving ondansetron alone compared with those receiving ondansetron and aprepitant, as measured by a peak nausea score (p = 0.014) and by multivariate analysis of variance results comparing repeated verbal rating scale scores over 48 hours after surgery (p = 0.024). In patients undergoing plastic surgery, the addition of aprepitant to ondansetron significantly decreases postoperative vomiting rates and nausea severity for up to 48 hours postoperatively. Therapeutic, II.
- Open Access
- 1 January 2012
- Published by Wiley in The Scientific World Journal
- Vol. 2012, 1-6
Efficacy of the Bilateral Ilioinguinal-Iliohypogastric Block with Intrathecal Morphine for Postoperative Cesarean Delivery Analgesia
The ilioinguinal-iliohypogastric (IIIH) block is frequently used as multimodal analgesia for lower abdominal surgeries. The aim of this study is to compare the efficacy of IIIH block using ultrasound visualization for reducing postoperative pain after caesarean delivery (CD) in patients receiving intrathecal morphine (ITM) under spinal anesthesia. Participants were randomly assigned to 1 of 3 treatment groups for the bilateral IIIH block: Group A = 10 mL of 0.5% bupivacaine, Group B = 10 mL of 0.5% bupivacaine on one side and 10 mL of a normal saline (NSS) placebo block on the opposite side, and Group C = 10 mL of NSS placebo per side. Pain and nausea scores, treatment for pain and nausea, and patient satisfaction were recorded for 48 hours after CD. No differences were noted with respect to pain scores or treatment for pain over the 48 hours. There were no differences to the presence of nausea (), treatment for nausea (), pruritus (), emesis (), or patient satisfaction (). There were no differences in pain and nausea scores over the measured time periods (MANOVA,). In parturients receiving ITM for elective CD, IIIH block offers no additional postoperative benefit for up to 48 hours.- 1 January 2012
- Published by Wiley in The Scientific World Journal
- Vol. 2012, 1-6
Open AccessEfficacy of the Bilateral Ilioinguinal-Iliohypogastric Block with Intrathecal Morphine for Postoperative Cesarean Delivery Analgesia
The ilioinguinal-iliohypogastric (IIIH) block is frequently used as multimodal analgesia for lower abdominal surgeries. The aim of this study is to compare the efficacy of IIIH block using ultrasound visualization for reducing postoperative pain after caesarean delivery (CD) in patients receiving intrathecal morphine (ITM) under spinal anesthesia. Participants were randomly assigned to 1 of 3 treatment groups for the bilateral IIIH block: Group A = 10 mL of 0.5% bupivacaine, Group B = 10 mL of 0.5% bupivacaine on one side and 10 mL of a normal saline (NSS) placebo block on the opposite side, and Group C = 10 mL of NSS placebo per side. Pain and nausea scores, treatment for pain and nausea, and patient satisfaction were recorded for 48 hours after CD. No differences were noted with respect to pain scores or treatment for pain over the 48 hours. There were no differences to the presence of nausea (), treatment for nausea (), pruritus (), emesis (), or patient satisfaction (). There were no differences in pain and nausea scores over the measured time periods (MANOVA,). In parturients receiving ITM for elective CD, IIIH block offers no additional postoperative benefit for up to 48 hours. - 31 December 2011
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 23 (8) , 653-656
Cesarean delivery in a parturient with syringomyelia and worsening neurological symptoms
- 31 December 2011
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 23 (8) , 653-656
Cesarean delivery in a parturient with syringomyelia and worsening neurological symptoms
- Open Access
- 1 June 2011
- Published by MDPI AG in Clinics and Practice
- Vol. 1 (3) , e57
Dexmedetomidine for an Awake Fiber-Optic Intubation of a Parturient with Klippel-Feil Syndrome, Type I Arnold Chiari Malformation and Status Post Released Tethered Spinal Cord Presenting for Repeat Cesarean Section
Patients with Klippel-Feil Syndrome (KFS) have congenital fusion of their cervical vertebrae due to a failure in the normal segmentation of the cervical vertebrae during the early weeks of gestation and also have myriad of other associated anomalies. Because of limited neck mobility, airway management in these patients can be a challenge for the anesthesiologist. We describe a unique case in which a dexmedetomidine infusion was used as sedation for an awake fiber-optic intubation in a parturient with Klippel-Feil Syndrome, who presented for elective cesarean delivery. A 36-yearold female, G2P1A0 with KFS (fusion of cervical vertebrae) who had prior cesarean section for breech presentation with difficult airway management was scheduled for repeat cesarean delivery. After obtaining an informed consent, patient was taken in the operating room and non-invasive monitors were applied. Dexmedetomidine infusion was started and after adequate sedation, an awake fiberoptic intubation was performed. General anesthetic was administered after intubation and dexmedetomidine infusion was continued on maintenance dose until extubation. Klippel-Feil Syndrome (KFS) is a rare congenital disorder for which the true incidence is unknown, which makes it even rare to see a parturient with this disease. Patients with KFS usually have other congenital abnormalities as well, sometimes including the whole thoraco-lumbar spine (Type III) precluding the use of neuraxial anesthesia for these patients. Obstetric patients with KFS can present unique challenges in administering anesthesia and analgesia, primarily as it relates to the airway and dexmedetomidine infusion has shown promising result to manage the airway through awake fiberoptic intubation without any adverse effects on mother and fetus.
- 1 June 2011
- Published by MDPI AG in Clinics and Practice
- Vol. 1 (3) , e57
Open AccessDexmedetomidine for an Awake Fiber-Optic Intubation of a Parturient with Klippel-Feil Syndrome, Type I Arnold Chiari Malformation and Status Post Released Tethered Spinal Cord Presenting for Repeat Cesarean Section
Patients with Klippel-Feil Syndrome (KFS) have congenital fusion of their cervical vertebrae due to a failure in the normal segmentation of the cervical vertebrae during the early weeks of gestation and also have myriad of other associated anomalies. Because of limited neck mobility, airway management in these patients can be a challenge for the anesthesiologist. We describe a unique case in which a dexmedetomidine infusion was used as sedation for an awake fiber-optic intubation in a parturient with Klippel-Feil Syndrome, who presented for elective cesarean delivery. A 36-yearold female, G2P1A0 with KFS (fusion of cervical vertebrae) who had prior cesarean section for breech presentation with difficult airway management was scheduled for repeat cesarean delivery. After obtaining an informed consent, patient was taken in the operating room and non-invasive monitors were applied. Dexmedetomidine infusion was started and after adequate sedation, an awake fiberoptic intubation was performed. General anesthetic was administered after intubation and dexmedetomidine infusion was continued on maintenance dose until extubation. Klippel-Feil Syndrome (KFS) is a rare congenital disorder for which the true incidence is unknown, which makes it even rare to see a parturient with this disease. Patients with KFS usually have other congenital abnormalities as well, sometimes including the whole thoraco-lumbar spine (Type III) precluding the use of neuraxial anesthesia for these patients. Obstetric patients with KFS can present unique challenges in administering anesthesia and analgesia, primarily as it relates to the airway and dexmedetomidine infusion has shown promising result to manage the airway through awake fiberoptic intubation without any adverse effects on mother and fetus.
- 1 October 2010
- Published by Elsevier in International Journal of Obstetric Anesthesia
- Vol. 19 (4) , 373-378
Ultrasound decreases the failed labor epidural rate in resident trainees
- 1 October 2010
- Published by Elsevier in International Journal of Obstetric Anesthesia
- Vol. 19 (4) , 373-378
Ultrasound decreases the failed labor epidural rate in resident trainees
- Open Access
- 1 January 2009
- Published by Hindawi Limited in The Scientific World Journal
- Vol. 9, 715-722
A 5-Year Audit of Accidental Dural Punctures, Postdural Puncture Headaches, and Failed Regional Anesthetics at a Tertiary-Care Medical Center
Obstetric anesthesia-related complications occur as a result of labor epidural or spinal placement. The purpose of this continuous quality-improvement audit was to review the occurrence of accidental dural punctures (ADPs), postdural puncture headaches (PDPHs), and failed regional anesthetics at an academic tertiary-care medical center over a 5-year period. Obstetric anesthesia complications contained in three databases consisting of ADPs, PDPHs, and failed regional anesthetics were matched to a perinatal database, with no complications serving as controls. Of the 40,894 consecutive parturients, there were 765 documented complications. Complication rates were 0.73% (95% CI: 0.65–0.82) for ADP, 0.49% (95% CI: 0.43–0.56) for PDPH, and 0.65% (95% CI: 0.57–0.73) for failed regional anesthetic. When compared to the no complication group, factors associated with obstetric anesthesia complications included increased weight and BMI (p< 0.01), epidural block (p< 0.01), and vaginal delivery (p< 0.01).
- 1 January 2009
- Published by Hindawi Limited in The Scientific World Journal
- Vol. 9, 715-722
Open AccessA 5-Year Audit of Accidental Dural Punctures, Postdural Puncture Headaches, and Failed Regional Anesthetics at a Tertiary-Care Medical Center
Obstetric anesthesia-related complications occur as a result of labor epidural or spinal placement. The purpose of this continuous quality-improvement audit was to review the occurrence of accidental dural punctures (ADPs), postdural puncture headaches (PDPHs), and failed regional anesthetics at an academic tertiary-care medical center over a 5-year period. Obstetric anesthesia complications contained in three databases consisting of ADPs, PDPHs, and failed regional anesthetics were matched to a perinatal database, with no complications serving as controls. Of the 40,894 consecutive parturients, there were 765 documented complications. Complication rates were 0.73% (95% CI: 0.65–0.82) for ADP, 0.49% (95% CI: 0.43–0.56) for PDPH, and 0.65% (95% CI: 0.57–0.73) for failed regional anesthetic. When compared to the no complication group, factors associated with obstetric anesthesia complications included increased weight and BMI (p< 0.01), epidural block (p< 0.01), and vaginal delivery (p< 0.01).
- 1 December 2007
- Published by Elsevier in The Journal of Pain
- Vol. 8 (12) , 970-975
Epidural Labor Analgesia: Continuous Infusion Versus Patient-Controlled Epidural Analgesia With Background Infusion Versus Without a Background Infusion
- 1 December 2007
- Published by Elsevier in The Journal of Pain
- Vol. 8 (12) , 970-975
Epidural Labor Analgesia: Continuous Infusion Versus Patient-Controlled Epidural Analgesia With Background Infusion Versus Without a Background Infusion